A total of 126 patients, whose superficial bladder tumours (Ta-Tl) had been removed by TUR, were subjected to local BCG therapy. Marked by frequent though mild side effects, they presented a significantly lower rate of tumour recurrence than the control group under exclusive TUR treatment. During a follow-up period of 3 years, 74% of the patients proved recurrence-free. BCG and Adriamycin were found largely similar in degree of effectiveness.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02583987DOI Listing

Publication Analysis

Top Keywords

local bcg
8
bcg therapy
8
superficial bladder
8
bladder tumours
8
therapy superficial
4
tumours total
4
total 126
4
126 patients
4
patients superficial
4
tumours ta-tl
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!